Rekord LOINC: 95130-1
Tylko wersja angielska ACTIVE
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
95130-1
FHIR
|
| Long Common Name: | Aggressive prostate cancer risk [Score] by Calculated by ExoDx |
| Short Name: | Aggr PC risk Score Patient Calc.ExoDx |
| Status: | ACTIVE |
| Class Type: | 1 |
Fully Specified Name (FSN)
Klasyfikacja
| Class: |
ENMOLPATH
|
| Consumer Name: | - |
| Order/Observation: | Both |
| Panel Type: | - |
Informacje dodatkowe
| Units Required: | - |
| Example Units: | score |
| UCUM Units: | {score} |
| Version Last Changed: | 2.69 |
Definicja i opis
This term was developed for ExoDx™ Prostate Test (IntelliScore). The ExoDx™ Prostate Test is a reverse-transcription PCR analysis of the genes PCA3, ERG, and SPDEF in urine. The ExoDx's IntelliScore is calculated based on a proprietary algorithm that uses PCA3, ERG, and SPDEF molecular results. The score is used to surmise the patient's risk of aggressive prostate cancer and help determine whether or not a biopsy should be performed. [PMID: 30129068] The ExoDx™ Prostate Test differentiates high and low grade cancer from benign diseases, using a cutoff score of 15.6. Patients with an Intelliscore above 15.6 are recommended for biopsy. [PMID: 27032035]
Powiązane nazwy
Aggr PC risk; Calc; Calc.ExoDx; Calculation; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale